r/DrugNerds • • Dec 29 '12

MDMA Supplementation

1.4k Upvotes

Ok, I did promise that I would make another post regarding supplementation to mitigate MDMA induced neurotoxicity. I have just been putting it off. Since my last post, I have gathered more information regarding my theory about MDA metabolism being the main cause of MDMA's neurotoxic effects. I will try to not get into that in this post, and keep this mostly about supplementation. As seems to be the norm with me, this may be long winded. Obviously everything I put on this list is not necessary. I will be placing supplements into different categories, with reasonings and references. I will let you decide which ones will be a part of your regimen.


Essential Supplements:

  • Alpha Lipoic Acid- This is one that everyone should be taking. It is a powerful antioxidant that scavenges reactive oxygen and nitrogen species. It also has a nice benefit of regenerating other vitamins, like C, after redox cycling. It exists in two enantiomers, R-ALA and S-ALA. R-ALA is the biologically active isomer that we are looking for. Most supplements are racemic, or a mix of both. Racemic ALA does not reach as high of plasma levels as R-ALA, nor does it stay in the blood as long. It's half life is very short, ~30min. If that is all you can find, it's much better than nothing. R-ALA by itself is very unstable, and is not suitable for supplementation. This is where bonding it to sodium comes into play. Na-R-ALA, or sodium R alpha lipoic acid, allows for stable delivery of just the dextrorotory isomer of ALA. Here is a study on the benefits of Na-R-ALA. And here is the study showing that ALA prevented MDMA induced neurotoxicity, even though body temperatures still rose.

Dosage and time schedule:

Racemic ALA- 200mg before MDMA dose and every hour of roll.

Na-R-ALA- 100mg before and every 2 hours of roll.

  • Bioavailable magnesium supplement- MDMA induces a release of extracellular glutamate in the hippocampus. Glutamate is the body's primary excitatory neurotransmitter. It binds to NMDA receptor sites, along with glycine, opening the ion channels and allowing calcium to enter the neuron. This is how the brain sends cascading electrical signals. When the ion channels open for too long or too frequently, calcium concentrations can become too high in the neuron. This can lower the effectiveness of your ion channels, or can even cause neuronal death. Magnesium is the substance your body uses to block the channel in a voltage-dependent manner. This means that the ion channel will not allow Ca2+ to pass, even if glutamate and glycine are bound to their receptor sites. However, once the neuronal membrane's electrical potential rises to an excited state, the Mg molecule will clear the channel and allow for normal operation. Most people are deficient in magnesium as it is. Supplementing a highly bioavailable magnesium supplement will give your body the substance it needs to naturally protect itself from excitotoxicity. Here is a picture I made to illustrate. There are a number of different types of magnesium supplements. Some are not absorbed very well, other are. The most common form, oxide, is one of the worst. This is where the concept of chelation comes into play. Magnesium is a substance the readily binds to insoluble salts in the stomach and intestines. This makes it hard to absorb. However, if you chelate the magnesium molecule to a soluble amino acid, it prevents it's binding to insoluble salts, as well as opening up the possibilities for active transport. This means that fully chelated magnesium is absorbed much better by the body. There are a number of different Mg/amino acid combinations. My favorite is magnesium glycinate. This is Mg chelated to a glycine molecule. It can be found cheaply and is highly bioavailable. There is also citrate, L-theonate, oroate, taurate, lysinate, etc. I will let you decide on which one you want to try.

Dosage and time schedule:

Magnesium Glycinate- 2,000mg (200mg elemental Mg) 6 hours before, 1 hour before, and during.

  • Vitamin C- This is a widely known antioxidant. It will help scavenge any reactive oxygen species that get created. It has been shown to prevent MDMA induced hepatotoxicity. It has also been shown to mitigate neurotoxicity as well. I like to take Emergen-C packets with me when I am on MDMA. This gives me C, plus electrolytes and a number of other substances. It will also raise stomach acidity, which will slow absorption of MDMA through the stomach and intestines. I take Tums 30min prior to MDMA to lower the acidity and increase absorption. I also drink it throughout the night, raising my urinary acidity. This allows me to excrete much of the MDMA in my urine before it metabolizes to harmful substances.

Dosage and time schedule:

Emergen-C packet- (1,000mg vitamin C) 1 hour before and during

  • Grape Seed Extract- GSA is a supplement high in vitamin E and flavonoids. Vitamin E deficiency has been shown to increase the severity of MDMA induced neurotoxicity. Also, flavonoids are potent antioxidants that will help protect against lipid oxidation and reactive oxygen species.

Dosage and time schedule:

Grape seed extract- 100mg before and during

  • Grapefruit Juice- My other post spoke about CYP3A4 metabolizing MDMA to MDA using N-demethylation. MDA is MUCH more neurotoxic than MDMA, and I spoke to why before. I am not going to rehash the specifics here, but there is no doubt that any MDA in your system is bad for you. The furanocoumarins present in grapefruit juice are potent CYP3A4 inhibitors. This study showed a 90% reduction in CYP3A4 metabolism after grapefruit juice ingestion. This study measured metabolism to MDA in humans. How much of your MDMA dose gets metabolized to MDA depends on a number of different factors, like dose, re-dosing schedule, body temperature, etc. Drinking grapefruit juice will drastically inhibit this metabolism. Your MDMA plasma levels will be higher when taking GFJ, so be aware of that when selecting dosages. It also has vitamin C and will increase stomach/intestinal/urinary acidity. This will help excrete MDMA in urine unmetabolized.

Dosage and time schedule: Drink some in the morning, an hour before drop, and some later in the night.


Suggested Supplements:

Dosage and time schedule:

ALCAR- 500mg before and during

Dosage and time schedule:

Green tea extract- 400mg before and during

  • 5-HTP- 5-HTP is the direct precursor to serotonin (5-HT). It is created from tryptophan in your diet using the enzyme tryptophan hydroxylase (TPH). MDMA can reduce TPH levels for weeks after use. This will make it harder for your body to produce the necessary 5-HT from normal dietary sources alone. Since 5-HTP does not need TPH, supplementing it the few days following your roll will help you body restore it's 5-HT levels. 5-HTP can pass your blood brain barrier, while 5-HT cannot. This means that when you supplement 5-HTP, you want to make sure it gets converted to 5-HT in your brain and not your periphery. The enzyme that converts 5-HTP to 5-HT is aromatic L-amino acid decarboxylase. It is found in your stomach and periphery, as well as your brain. This means that we have to inhibit it, so that your 5-HTP has time to pass your blood brain barrier. EGCG is an inhibitor of L-amino acid decarboxylase (Also known as DOPA decarboxylase). ALWAYS take EGCG with your 5-HTP to ensure that your brain is getting the serotonin, and not your periphery. Excess 5-HT in the periphery can cause heart valve damage.

Dosage and time schedule:

5-HTP (with 400mg EGCG)- 100mg before bed for 3-7 days following MDMA use

  • Melatonin- Melatonin is created from serotonin. Your body uses it to control sleep/wake cycles. It is also a very powerful antioxidant. After using MDMA, your serotonin levels will be low, and your melatonin levels will be affected. Taking a melatonin supplement before bed will help you sleep, but will also help scavenge any oxidative substances your other antioxidants have missed.

Dosage and time schedule:

Melatonin- 5-10mg before bed (Keep in mind we are using a higher dose here for it's antioxidant properties. Normal dosages should be .5mg to 1mg.)

  • CoQ10- When your NMDA receptors open and allow Ca2+ to influx into the neuron, that calcium must then be pumped back out of the neuron to bring it back down to resting potential. Protein pumps are what force the Ca2+ back into the extracellular space. To do this, they need andenosine triphosphate (ATP). CoQ10 is used by your body to synthesize ATP, which will allow your protein pumps to be able to expel the excess Ca2+ more efficiently. This will protect your neurons from exitotoxicity.

Dosage and time schedule:

CoQ10- 100mg before


There's more to talk about, but I am tired. This should do for now. Don't forget water and electrolytes, and KEEP YOUR BODY TEMPERATURE DOWN.


r/DrugNerds • • Jan 21 '19

Sasha Shulgin smiling in his lab

Post image
1.2k Upvotes

r/DrugNerds • • Oct 16 '19

Sasha Shulgin smiling in his lab

Post image
890 Upvotes

r/DrugNerds • • Mar 21 '17

Incorrect tattoo NSFW

683 Upvotes

I'm not sure if you try to keep this subreddit clear of lighthearted content and focused on discussion, but it's the best place I could think of to post this since it would resonate most with the type of people who come here.

I was watching porn a moment ago and there was a part where you get a really good look at a tattoo on the pornstar's thigh... and it is this abomination:

Image cropped to make it SFW

Unedited/overtly NSFW version

There should be a double bond on the 5-member ring because the whole bicyclic portion of DMT is aromatic.

It ruined the video for me. All I could think about was her bad tattoo so I just stopped the video and came here to make this post. I don't even understand how it would happen because someone who doesn't know the structure of the molecule would just grab a picture online and show that to the tattoo artist. Maybe her tattoo artist sucks.

Or maybe... maybe she actually wanted a tattoo of 2,3-dihydro-N',N'-dimethyltryptamine and people these days are getting into "research chemicals" that weren't used back when I was into that stuff. I found this paper from 1982 saying it has about half the affinity for 5-HT receptors as DMT; maybe it has similar effects.

...It's probably just a bad tattoo.


r/DrugNerds • • Jun 08 '19

Drug Interactions 2.0

Post image
614 Upvotes

r/DrugNerds • • Jan 17 '20

Man does 157 drugs in order to write safety guide

Thumbnail
freethink.com
611 Upvotes

r/DrugNerds • • Feb 17 '20

A timeline of the federal legality of 12 drugs in the United States (also plots when the synthetic drugs were created).

Post image
576 Upvotes

r/DrugNerds • • Jan 08 '19

Campaign to decriminalize psychedelic mushrooms in Denver says it has enough signatures to make the ballot

Thumbnail
ktvb.com
545 Upvotes

r/DrugNerds • • Jan 19 '14

Erowid's Future

515 Upvotes

TL;WR: Erowid is outdated, it needs a community to stay relevant, we should therefore make one (please read, though :) )

Here's a nice song to listen to while reading.

We need to have a talk about information sources.

Most of us have been around for a while, and are deft source-seekers. We can sniff out a vetted academic review tucked in a remote corner of PubMed. We have extensive background knowledge. We don't need concise, compiled sources.

The masses of casual experimentors, however, do. If you're reading this, you've likely given advice to many people asking for information on a drug. You've probably directed them to Erowid.

Erowid makes sense. An independent, subject-specific site is simply our best option. The alternative is Wikipedia, but they dislike subjective, primary, or layman sources. This standard prevents us from incorporating crucial emerging information on RCs, and from thoroughly describing subjective effects (which are the core interest of most readers). Erowid has been the Web's reliable and comprehensive drug information resource for almost two decades.

But Erowid is falling behind. I'm not trumpetting Web 2.0 hokum or disregarding Fire and Earth's tireless efforts. I simply want to publicly address some issues in the site's infrastructure that are causing stagnation. I am not finger-pointing or deriding, nor am I trying to commandeer the site. The tone, I hope, is frank but respectful. You may agree with some points but not others; I'll stay brief and objective, so try to stick with me all the way through.

The most obvious problem is the design. The earliest available archive of the home page, from November 1999, reveals a very similar site. The August 2004 archive (which redirects to the June 2006 archive because they are identical) is nearly indiscernable from the current design.

Design isn't what makes a site valuable or useful; content comes first. However, design this outdated harms Erowid. Imagine today, as a sixteen-year-old, visiting Erowid for the first time. Does it convey authority, or suggest up-to-date content? Additionally, try browsing Erowid on your smartphone. While there are apps available, the lack of a mobile stylesheet deters people arriving on smartphones through search engines.

I'm not suggesting that we make-over Erowid with a bubbly Bootstrap-like veneer. We should, however, consider options that make it more readable and authoritative.

The content is aging along with the design. Science is still deciphering the actions and effects of all drugs, and many recent revelations haven't found their way into Erowid's vaults. Opioid-induced hypogonadism, for example, and ketamine's lack of acute neurotoxicity, are absent. This deprives less informed readers of important knowledge, and alerts more experienced ones to the dated nature of the site.

Erowid once served as a “best of” for communities like ours. The teks (do we still call them that?) were considered reliable and safe, reducing the ceaseless reanswering of noob questions in forums and usergroups. Erowid separated the signal from the noise; no one had to trust the random incoherant galoot on Bluelight that Google turned up. Erowid set standards, supporting safe use and focused progress. Teks are rarely added these days. Over the years, browsing Erowid feels more and more like perusing a museum of 1990's drug culture. Indeed, there is a slow but steady decline in Erowid's Alexa traffic ranking.

These issues distill to one eminently solvable problem: Erowid lacks a community, and it needs one. Unless I was silently unsubscribed, the last email on the volunteer mailing list was a year ago last Wednesday.

We cannot and do not expect Fire and Earth to maintain and update the site as needed. It's not-for-profit, and even if they neglected their outside lives to slave at improvement they couldn't reach our ideal. Why? Because they aren't professional web designers, programmers, pharmacologists, or lawyers. Erowid is simply too big and diverse a project for anyone to cultivate alone.

I'm discussing this because I care, and because I still believe in Erowid. There must be many people willing to contribute to a major renovation; I'm one of them.[1] Those who specialize in web design should begin prototyping a new stylesheet. I and my pharmacology-obsessed brethren should form an internal wiki to edit and update Erowid vaults. We should start a public discussion with Fire and Earth. Potential volunteers shouldn't have to hunt for ways to contribute, they should be publicly offered. We could have a priority list, an IRC channel, a style guide... a community.

Increasing Erowid usership doesn't just inflate our egos or the server bill, it benefits public health and saves lives. I'm not trying to make myself the masthead of an Erowid restoration, but I'd sure participate. How about you?

[1] In fact, this would require little additional effort, considering that most of my work on Wikipedia is also relevant to Erowid. I'm sure others are in the same situation.

EDIT: Speak your mind in the comments! Let's get this ball rolling!

EDIT 2: It appears that the EncyclopediaPsychonautica community has decided to use this post for promotion. I have nothing against your project, but I (and I suspect most others here) want to focus on improving Erowid, not replacing it. Thanks.

EDIT 3: The above applies to all other sites as well. I support having a diverse set of drug information sites, but this discussion's subject is improvement rather than replacement.

In other news, I was just linked to Erowid's 2013/2014 prospectus in the comments by /u/Jhoppa (thanks!). It seems like a great resource and I'm disappointed that I overlooked it. I'm about to read it.

Keep giving opinions! I'm trying to respond to everyone, so make sure I haven't addressed your points in the original post or in another reply. Also, any offers of help are greatly appreciated.

Finally, the most important current objective is starting a public conversation with Erowid's administrators ASAP. I'm still working on making that happen. When it does, please be respectful and appreciative.

And finally, thanks so much for your warm reception and thoughtful opinions! I'm confident that we can make a difference.

EDIT 4: Earth Erowid just posted a thorough response!


r/DrugNerds • • Jul 18 '19

Combining MDMA with SSRIs - Are there possible dangers? A review of recent literature

496 Upvotes

Note: It's been a while since I've done any serious reading of scientific papers, so I might be completely off base here. Please let me know if I am.

Does combining MDMA and SSRIs put you at a fatal risk of serotonin syndrome? This seems to be common knowledge in many parts of the internet, but where is the evidence? I had seen a number of papers to the contrary, which indicated that SSRIs would be neuroprotective against the harms of MDMA. However the "common knowledge" must have come from somewhere. Was I just missing some vital information? Luckily a quick google search brought up a relatively recent (2013) paper that seems to be trying to summarize the research about the interaction of MDMA and SSRIs, with a view of warning the world.

Dobry, Y., Rice, T., & Sher, L. (2013). Ecstasy use and serotonin syndrome: a neglected danger to adolescents and young adults prescribed selective serotonin reuptake inhibitors. International Journal of Adolescent Medicine and Health, 25(3). doi:10.1515/ijamh-2013-0052

https://sci-hub.se/10.1515/ijamh-2013-0052

Well the title certainly indicates that the authors think there is a risk. Lets give this a read. From the abstract:

MDMA, in combination with the widely prescribed SSRI antidepressant class, can lead to rapid, synergistic rise of serotonin (5-HT) concentration in the central nervous system, leading to the acute medical emergency known as serotonin syndrome.

Well that seems pretty definitive. Lets see how they came to that conclusion.

The paper starts by giving an overview of how SSRIs and MDMA work, and the mechanisms of serotonin syndrome. Lets skip that and get into the meat of it though.

Ecstasy in combination with SSRI increases the risk of serotonin syndrome

Now that's the title we've been looking for. Surely all the facts are in here.

Despite a clear need, basic and clinical science has done little to investigate a physiological interaction between SSRIs and MDMA This omission disregards the powerful potential of both drugs to tremendously raise synaptic cleft serotonin. Microdyalisis and measured lab data has shown that SSRIs are capable of very rapid, and large increases of serotonin (5-HT) concentration in animal brains (60–62), and that MDMA administration releases serotonin at various brain sites at a rate possibly above that produced by the SSRIs (63, 64).

That's in isolation though, what about when they are combined?

The combined pharmacokinetic drug-drug interaction additionally ensues when SSRIs that are also potent CYP450 2D6 inhibitors reduce MDMA metabolism (53, 65). MDMA can conversely exert metabolic effects upon SSRI metabolism. Paroxetine and fluoxetine administration, for example, has been shown to increase MDMA levels by as much as 30% (66)

Well, the amount of MDMA in the blood being elevated to that degree does sound alarming, especially if it's releasing all that serotonin. Lets look at the cited paper.

(66) Farre M, Abanades S, Roset PN, Peiró AM, Torrens M, et al. Pharmacological interaction between 3,4-methylenedioxy-methamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics. J Pharmacol Exp Ther 2007

http://public-files.prbb.org/publicacions/b52755a0-7bd7-012a-a768-000c293b26d5.pdf

Even though plasma concentrations of MDMA were increased, a boost in pharmacological and subjective effects was not observed. On the contrary, a clear decrease was observed, which indicates a pharmacodynamic interaction.

Hmm, it seems like this is more complicated than just blood levels.

In vitro studies have shown that fluoxetine inhibits MDMA-induced release of serotonin into the synaptic space (Gudelsky and Nash, 1996), and there is some evidence that pre-treatment with SSRIs reduces some MDMA-related effects (Liechti et al., 2000; Liechti and Vollenweider, 2000b; Tancer and Johanson, 2007). SSRIs, such as paroxetine, antagonize MDMA activity either by preventing its interaction with the 5-HT uptake site or alternatively by blocking the efflux of 5-HT through the carrier.

Oh. So even with more MDMA in the blood, less serotonin is being released. I'm not seeing where serotonin syndrome would come from. Maybe there are other sources? Lets get back to the main paper.

Moreover, increased body heat from muscle use during prolonged dancing and cooling dysregulation brought about by dehydration can significantly increase body temperature, leading to an excessive increase in the serotonin release rate through the amplified thermodynamic processes (70, 71).

Well I can't find fault with thermodynamics. This seems unrelated to SSRIs though, getting too hot is classic MDMA. What happens with SSRIs in the mix? Lets get back to citation 66.

During the paroxetine condition, the increase in temperature shown during the administration of MDMA alone decreased by approximately 50%.

So adding SSRIs to the MDMA would reduce the amount of serotonin released via thermodynamics, not increase it. Another dead end. I'm beginning to wonder how deeply the authors read the papers they cited.

Well the pharmacological dynamics seem to be a bust for causing serotonin syndrome, but those were all measured in sterile laboratories. The real world can be messier and throws in curveballs. Do they have any data about it happening in the real world?

A survey of 216 young adults from Sydney, Australia who had used Ecstasy at least once in the previous 6 months reported 19 cases of purposeful concomitant use of antidepressant medication with MDMA. A considerable number of these subjects took the SSRI either to enhance their Ecstasy high or to prevent neurotoxic effects. This sample was analyzed for neuropsychiatric symptoms and a large proportion has been shown to display symptoms consistent with serotonin syndrome of various severity (75)

This seems to show exactly what I was talking about, lets see the facts on the ground. The paper cited:

(75) Copland J, Dillon P, Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addict Behav 2005;31:367–70

https://sci-hub.se/10.1016/j.addbeh.2005.05.025

Only four pages, extremely brief

SSRI and MAOI antidepressants were reported 19 times

The paper grouped SSRIs and MAOIs in a single category when reporting symptoms resulting from MDMA combined with antidepressants - Cited only as SSRIs. That's no good. We know that MAOIs can cause serotonin syndrome when combined with MDMA (and lots of other drugs). That's going to really skew the results.

However that paper was also concerned about this risks of MDMA and anti-depressants.

This is of concern, as some of these ecstasy-pharmaceutical combinations can have potentially serious health consequences (Singh & Catalan, 2000; Sternbach, 1991)

Lets keep going down the chain and read the papers they used to come to this conclusion.

Singh, A. N., & Catalan, J. (2000). Rave drug (ecstasy) and selective serotonin reuptake inhibitor anti-depressants. Indian Journal of Psychiatry,42(2), 195–197.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957712/pdf/IJPsy-42-195.pdf

We report two cases of misuse of selective serotonin re-uptake inhibitors (SSRIs) antidepressants in combination with Ecstasy and their beneficial subjective effects experienced by misusers. We hypothesis the probable underlying pharmacological reasons and recommend its use in the treatment of neurotoxic effects of MDMA

Where is the harm? Not in this paper. They actually come to the opposite conclusion.

Sternbach, H. (1991). The serotonin syndrome [comment].American Journal of Psychiatry,148(6), 705–713.

https://sci-hub.se/10.1176/ajp.148.6.705

A paper about the dangers of serotonin syndrome – Focused on MAOIs (don’t combine them with your lithium) Zero mention of MDMA, and only really mentions SSRIs in terms of them being combined with MAOIs (don't).

It seems like when you dig into the citations of harm there is almost zero evidence of the claims they are supposed to support. To really demonstrate that, lets finish up back at Dobry et al

One of the case reports even describes death from the combination of fluoxetine and MDMA (84)

Bold is mine.

Have we finally found the harm? A full case report showing the fatal combination of SSRIs and MDMA?

(84) Byard RW, Gilbert J, James R, Lokan RJ. Amphetamine derivative fatalities in South Australia-is “Ecstasy” the culprit? Am J Forensic Pathol 1998;19:261–5.

http://www.maps.org/images/pdf/1998_byard_1.pdf (Thanks MAPS!)

A collection of six case reports of deaths related to "ecstasy", including a single case where fluoxetine was present.

Toxicologic analysis of blood revealed elevated, but apparently not lethal, levels of PMA, with therapeutic levels of fiuoxetine (Prozac). Ecstasy not detected.

Bolds are mine.

PMA and a SSRI, not MDMA and a SSRI. PMA can be fatal if a user mistakes it for MDMA, but if a scientific author makes the same mistake it can really fill in the gaps in their evidence.

Overall my confidence in peer-review has really taken a hit after going through this. Now I'm wonder how many other papers I've taken on faith can also be taken to pieces by actually checking the citations. I've actually been convinced that SSRIs can really help with protecting from some of the damage MDMA might cause, and I'm planning on popping some paroxetine on the comedown of my next roll.


r/DrugNerds • • Jan 12 '20

Found in an antique store this weekend

Post image
488 Upvotes

r/DrugNerds • • Aug 30 '18

Event with actual drug expertise and lab vs. festival which lets college social media intern be responsible for "safety".

Post image
471 Upvotes

r/DrugNerds • • Oct 14 '19

New $17 million psychedelics research center to open at Johns Hopkins

Thumbnail
freethink.com
447 Upvotes

r/DrugNerds • • Apr 06 '24

Erowid's Online Drug Information Servers (Erowid.org and DrugsData.org) Down Today

442 Upvotes

Starting at 2pm PDT and going until late this evening, our main servers will be down. I tried to post this to r/drugs but it got mod-deleted. Seems related to me, thought someone might ask. Hope it fits in DrugNerds?

It's been 10 years since the last time we had to take our main servers down. But we had to move physical data centers for complex reasons, so this requires physically moving our owned hardware to Santa Clara from South San Francisco. Machines are now offline, packing up the PDUs, the firewall appliance, etc and then driving them to new location!Always an unknown when old hardware that's been running so long gets fully powered off or if we'll have trouble with the networking config at the new location...

Everything back up and working now in the new data center as of around 5pm. Hurray!

Service interruption complete.


r/DrugNerds • • Jan 08 '20

I've been creating an App to help me see how meds/supplements and other factors impact my mood and symptoms

Post image
439 Upvotes

r/DrugNerds • • Nov 04 '20

Breaking News: Oregon Legalizes Psilocybin Therapy

Thumbnail
doubleblindmag.com
432 Upvotes

r/DrugNerds • • Jun 03 '14

RIP Alexander Shulgin

424 Upvotes

https://www.facebook.com/photo.php?fbid=686340134765289&set=a.297028843696422.68924.287638407968799&type=1&theater

The text reads:

Dear Friends,

Sasha died today, at exactly 5 o'clock in the afternoon. He was surrounded by family and caretakers and Buddhist meditation music, and his going was graceful, with almost no struggle at all.

Thanks to all of you, and Blessings,

Ann Shulgin


r/DrugNerds • • Aug 01 '17

After burying my head in scientific journals and neuroscience books for months, I think I finally understand how psychedelic drugs work in the brain. This is my attempt of explaining it in 10 minutes with infographics and cartoons.

Thumbnail
sapiensoup.com
422 Upvotes

r/DrugNerds • • Nov 25 '19

I summerized Germanys drug related deaths (2017)

Post image
415 Upvotes

r/DrugNerds • • Aug 26 '19

31% of CBD products were labeled correctly, 43% contained far less CBD than claimed, and many had more than 0.3% THC. Vaporization liquids were labeled correctly 12.5% of the time.

Thumbnail
today.uconn.edu
410 Upvotes

r/DrugNerds • • Aug 14 '19

How to tell if you're taking too many psychedelics or hallucinogens

408 Upvotes

Tracking long-term effects of psychedelic drugs

When used effectively, hallucinogens can bring on altered states of consciousness that constitute immense therapeutic value. To reduce risk and ensure healing psychedelic sessions, users should exercise moderation, track their usage patterns, and monitor long-term effects. For this purpose, it is recommended that any psychedelic user keep a log of their psychedelic sessions, dosages, and experiences. This can be elaborated with journal entries, diagrams, and illustrations.

When self-medicating with psychedelics on a regular basis, it is not uncommon for the patient to find themselves managing significant emotional and psychological changes. This is sometimes accompanied by a double bind in which the psychedelic experience feels healing, but is overshadowed by an intensification of symptoms or life changes over an extended period. In these cases it is important for the user to stop, step back, and take notes of any impact psychedelics are having on various aspects of life:

  • Emotional well-being: Prioritize your journey towards joyful contentment. Remaining open to new experience, patience, a sense of belonging, kindness toward others, and loving acceptance of oneself.

  • Social relationships: Be vigilant of any changes to relationships with family and longstanding friends. Associate with people who have your best interest in mind, and be wary of strangers that encourage irresponsible behavior. Befriend people who make you feel safe and offer to provide mutual support.

  • Responsibilities: Keep track of changes to your attendance or performance at work and school. Be sure you are able to support yourself and those dependent on you. Aim to earn a life that is creatively, emotionally, and socially fulfilling.

  • Neurological health: Strive to feel safe, secure, and comfortable. Note if you begin to experience scrambled thoughts, obsessive dwelling, increased dissociation, heightened startle response, hallucinations, or other persistent alterations to cognition. These may be signs that you could benefit from psychedelic integration therapy and complementary therapeutic practices, and are often signs to slow down drug intake.

  • Physical health: Note changes to appetite, energy levels, and general well-being. Note muscle spasms, tightness, gastrointestinal upset, and other symptoms which can be invoked by regular drug use. Maintain a nutritious diet, do routine exercise or physical therapy, monitor changes to health, and care for one’s body as a vehicle for well-being.

These considerations are adapted from systems such as Maslow’s Hierarchy of Needs and principles from Dialectical Behavioral Therapy.[1]

Adverse effects of psychedelic use

There are some common types of unanticipated behavior and symptoms that may arise from psychedelic use. These are described below. When dealing with any of the following complications, it is important to seek additional support to ensure one’s well-being.

In clinical psychedelic therapies, Cognitive Behavioral Therapy (CBT) and Dialectical Behavioral Therapy (DBT) are widely used for providing a therapeutic foundation adjacent to psychedelic therapy.[2] Complementary therapy practices and art therapy may be useful for managing flashbacks and other intrusive or overwhelming side-effects.[3][4][5] Experienced psychedelic therapist or organizations can offer additional support.

Hallucinogen persisting perceptual disorder (HPPD)

HPPD is among the most common side effects of psychedelic use. After taking high doses of psychedelics, the user may acutely re-experience psychedelic phenomena throughout daily life. This consists of persistent changes to sensory experiences, often visual. In research, two types of HPPD are sometimes distinguished: short-term and effects that are benign and reversible (type I), and intense long-term persistent effects that cause distress (type II).[6]

Effects of HPPD include visual snow or static, halos or auras surrounding objects, trails or afterimages left by moving objects, increased visibility of floaters, difficulty reading text due to visual disturbances, confusing colors with one another, intensified colors, inability to discern the size of objects, increased hallucinatory phenomena when entering or leaving sleep, geometric hallucinations (with both closed and open eyes), flashes of color, illusions of movement (especially in peripheral vision), increased pattern recognition, pareidolia, and intensified sensory experiences.[7][8][9] Cannabis use may intensify or trigger HPPD.[10] Environments, memories, or sensory stimuli that are reminiscent of a past psychedelic trip can sometimes trigger a flashback.[11]

Flashbacks may feel pleasant, benign, or intrusive. HPPD type I often subsides over time provided sobriety, emotional stability, and self-care. HPPD type II can be managed using psychiatric medication including antipsychotic and antiepileptics, and also may lessen over time.[12]

Re-exposure to traumatic memories

Psychedelic possess the ability to increase connectivity between brain regions, exposing their user to unusual thought patterns and ideas. This increased connectivity can also invoke suppressed or traumatic memories. During therapy sessions, the guide or therapist may encourage the participant to trust in their inner resources when re-experiencing traumatic associations. Integration therapy may help ensure that the participant is able to successfully translate intense psychedelic sessions into constructive and worthwhile experiences. Participants who manage traumatic memories through art therapy may prefer to keep their artwork private, depending on their comfort level.[13]

Escapism

Hallucinatory landscapes and omnipotent intelligence are among many fantastic things that may be elicited in altered states. Because of the novelty of these states, some users may become dependent on psychedelics to chase cognitive, aesthetic, and spiritual highs. Users often seek escapism due to difficult life circumstances or mental illness, which can also indicate increased psychological risks with regular psychedelic use.

Delirious or obsessive thinking

Although they can elicit incredible thought connectivity and epiphany, psychedelics also may elicit delirious or obsessive thought patterns in some individuals. This can occur due to a vulnerable mindset that was overlooked during participant screening, or as a result of adverse events during the psychedelic experience itself. Integration therapy and complementary therapy practices are helpful for organizing confusing memories and ideas within a stable conceptual framework. Some users with obsessive thought patterns also exhibit a compulsion to write, draw, perform, or otherwise express themselves; creative expression may be especially relevant for these patients’ integration process.[14]

Dissociative symptoms

For some individuals psychedelics can invoke dissociation, depersonalization, or derealization. These conditions are frequently regarded as traumagenic or neurodevelopmental in origin, and like disorganized thinking, may be brought on or intensified by psychedelic drugs.[14] When dealing with this set of symptoms, complementary therapy practices that are strongly focused on reducing dissociation are recommended.

Works cited

  1. McLeod, S. A. (2018, May 21). Maslow’s hierarchy of needs. Retrieved from https://www.simplypsychology.org/maslow.html

  2. Reed, G. (2019, August). Psychedelic therapy. Effect Index.

  3. Pifalo, T. (2007). Jogging the Cogs: Trauma-Focused Art Therapy and Cognitive Behavioral Therapy with Sexually Abused Children. Art Therapy, 24(4), pp.170-175. Retrieved from https://archive.org/details/ERIC_EJ791441. 10.1080/07421656.2007.10129471.

  4. Chapman, L., Morabito, D., Ladakakos, C., Schreier, H., & Knudson, M. (2011, Apr 22). The Effectiveness of Art Therapy Interventions in Reducing Post Traumatic Stress Disorder (PTSD) Symptoms in Pediatric Trauma Patients. Art Therapy, 18:2, 100-104. https://doi.org/10.1080/07421656.2001.10129750.

  5. Schouten, K. A., de Niet, G. J., Knipscheer, J. W., Kleber, R. J., & Hutschemaekers, G. J. M. (2015). The effectiveness of art therapy in the treatment of traumatized adults: A systematic review on art therapy and trauma. Trauma, Violence, & Abuse, 16(2), 220-228. http://dx.doi.org/10.1177/1524838014555032.

  6. Elkins C., Rosenberg J. (2019, July 13). Hallucinogen Persisting Perception Disorder (HPPD). Drugrehab.com. Retrieved from https://www.drugrehab.com/addiction/drugs/hallucinogens/hppd/.

  7. Hermle, L., Simon, M., Ruchsow, M., & Geppert, M. (2012). Hallucinogen-persisting perception disorder. Therapeutic advances in psychopharmacology, 2(5), 199–205. doi:10.1177/2045125312451270

  8. Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017). The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. Frontiers in psychiatry, 8, 240.

  9. Hallucinogen persisting perception disorder. (2019, May 31). PsychonautWiki. Retrieved from https://psychonautwiki.org/w/index.php?title=Hallucinogen_persisting_perception_disorder.

  10. Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., … & Lerner, A. (2018). Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain sciences, 8(3), 47.

  11. Abraham, H. D. (1983). Visual phenomenology of the LSD flashback. Archives of General Psychiatry, 40(8), 884-889.

  12. Lerner, A. G., Rudinski, D., & Bor, O. (2014). Flashbacks and HPPD: A clinical-oriented concise review. The Israel journal of psychiatry and related sciences, 51(4), 296.

  13. Gidron, Y., Peri, T., Connolly, J. F., & Shalev, A. Y. (1996). Written disclosure in posttraumatic stress disorder: Is it beneficial for the patient? Journal of Nervous and Mental Disease, 184(8), 505-507. http://dx.doi.org/10.1097/00005053-199608000-00009

  14. LaPlante, E. (2016, June 14). Seized: Temporal Lobe Epilepsy as a Medical, Historical, and Artistic Phenomenon (pp. 246-248). Open Road Media. Retrieved from https://play.google.com/store/books/details?id=pxauCwAAQBAJ.


This article is a part of https://www.psychedelic.training, a freely-licensed collection of materials covering psychedelic harm reduction and complementary therapies. If you have any suggestions or corrections to the above, please reply and start a conversation. This article is a Free Cultural Work available for reproduction and adaptation under the CC BY-SA 4.0 license: https://creativecommons.org/licenses/by-sa/4.0/


r/DrugNerds • • Dec 21 '18

Ever wondered why fungi contain compounds that affect human cognition? It's because our unicellular ancestors shared ancient neurotransmitters that pre-dated the evolution of the brain. - Prof. Michael Levin NeurIPS 2018

Thumbnail
youtube.com
404 Upvotes

r/DrugNerds • • Dec 11 '20

Hamilton Pharmacopeia Season 3 Trailer

Thumbnail
youtu.be
403 Upvotes

r/DrugNerds • • Jan 31 '25

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

Thumbnail
pubmed.ncbi.nlm.nih.gov
391 Upvotes

r/DrugNerds • • Feb 05 '21

Cambridge Votes To Decriminalize Psychedelics And All Controlled Substances

Thumbnail
wbur.org
391 Upvotes